Long-term efficacy and safety of a calcineurin inhibitor-free regimen in live-donor renal transplant recipients.
Hamdy AF, Bakr MA, Ghoneim MA. J Am Soc Nephrol. 2008 Jun;19(6):1225-32
Related Articles:
- Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial
- Conversion of Long-Term Kidney Transplant Recipients From Calcineurin Inhibitor Therapy to Everolimus: A Randomized, Multicenter, 24-Month Study
- Switching from Calcineurin Inhibitor-based Regimens to a Belatacept-based Regimen in Renal Transplant Recipients: A Randomized Phase II Study
Recent Comments